| Financial Year |
March 31 2023 |
| Monetary Funds |
6,065,287,841.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
467,179,071.27 |
| Accounts Receivable |
1,114,421,835.79 |
| Advances to Suppliers |
502,170,636.41 |
| Other Receivables |
173,469,660.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,062,554,636.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
506,151,687.23 |
| Total Current Assets |
13,666,091,809.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,165,672,803.61 |
| Investment Properties |
261,746,160.74 |
| Fixed Assetes |
17,946,427,818.62 |
| Under-construction Projects |
2,429,428,772.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
116,548.33 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,288,819,140.96 |
| R&D expenses |
-- |
| Goodwill |
4,785,722.54 |
| Long-Term Deferred and Prepaid Expenses |
453,997,540.88 |
| Deferred Income Tax Assets |
187,554,443.25 |
| Other Non-Current Assets |
248,858,689.50 |
| Sub-Total of Non-Current Assets |
35,451,785,280.24 |
| Total Assets |
49,117,877,089.39 |
| Short-Term Loans |
4,617,929,618.12 |
| Trading Financial liabilities |
177,177,480.00 |
| Notes Payable |
1,022,818,743.90 |
| Accounts Payable |
6,629,389,521.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
220,829,720.34 |
| Taxes Payable |
461,421,264.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
678,856,148.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
538,002,427.95 |
| Other Current Liabilities |
547,426,472.44 |
| Sub-Total of Current Liabilities |
16,162,193,589.24 |
| Long-term Loans |
3,036,173,333.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,119,711,963.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
193,397,429.90 |
| Other Non-Current Liabilities |
26,855,759.53 |
| Sub-Total of Non-Current Liabilities |
5,787,672,605.14 |
| Total Liabilities |
21,949,866,194.38 |
| Paid-In Capital(Or Share Stock) |
1,999,125,896.00 |
| Capital Surplus |
3,198,395,968.96 |
| Surplus Reserve |
1,877,276,942.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,148,073,569.11 |
| Minority Stockholder's Interest |
5,742,117,709.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,425,893,185.33 |
| Owner's Equity（Stockholder's Equity） |
27,168,010,895.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,117,877,089.39 |
